M&G plc’s Astera Labs ALAB Stock Holding History

M&G plc’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-159,570	Closed	-$9.57M	–	477
2025 Q1	$9.57M	Buy	+159,570	New	+$14.8M	0.05%	210

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

M&G plc's ALAB Position: Q2 2025 in Review

M&G plc sold out of Astera Labs (ALAB) in Q2 2025, closing a stake of 159,570 shares — an estimated $9.57M sold.

M&G plc first reported a position in ALAB in Q1 2025 and held it in 1 quarter. The position peaked at $9.57M in Q1 2025. 513 funds tracked by Wall St. Rank hold ALAB as of Q2 2025.

M&G plc reported no remaining Astera Labs position as of Q2 2025 after selling out during the quarter.
M&G plc sold 159,570 Astera Labs shares in Q2 2025, an estimated $9.57M.
M&G plc first reported a position in Astera Labs in Q1 2025 and held it in 1 quarter.
M&G plc's Astera Labs position peaked at $9.57M in Q1 2025.
513 funds tracked by Wall St. Rank held Astera Labs as of Q2 2025.

Based on M&G plc's 13F filing for Q2 2025, filed 8 Aug 2025.